Literature DB >> 2837955

Novel molecules that antagonize leukotriene B4 binding to neutrophils.

A H Lin1, J Morris, D G Wishka, R R Gorman.   

Abstract

A series of LTB4 analogues have been synthesized that replace carbons 7-9 of the cis-trans-trans triene unit of LTB4 with a stable ring structure. Meta-substituted pyridine analogues are more potent inhibitors than benzene or furan analogues. C-1 alcohols are often more potent inhibitors than free carboxylic acids, and 5,6-cis double bond compounds are more potent than 5,6-trans compounds. Compounds such as these may prove to be useful in the treatment of inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837955     DOI: 10.1111/j.1749-6632.1988.tb38542.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

1.  Leukotriene B4 activates intracellular calcium and augments human osteoclastogenesis.

Authors:  Neha Dixit; Dennis J Wu; Yesser H Belgacem; Laura N Borodinsky; M Eric Gershwin; Iannis E Adamopoulos
Journal:  Arthritis Res Ther       Date:  2014-12-02       Impact factor: 5.156

2.  Novel mechanism of regulation of the 5-lipoxygenase/leukotriene B4 pathway by high-density lipoprotein in macrophages.

Authors:  Shigeyasu Tsuda; Masakazu Shinohara; Toshihiko Oshita; Manabu Nagao; Nobuaki Tanaka; Takeshige Mori; Tetsuya Hara; Yasuhiro Irino; Ryuji Toh; Tatsuro Ishida; Ken-Ichi Hirata
Journal:  Sci Rep       Date:  2017-10-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.